IBM’s Rare Double Act: Nvidia Hardware and Software Growth Converge to Lift Shares to Record

The stars are aligning for IBM in a way they haven’t in decades. What started as a quiet rally in the software division has been turbocharged by an unexpected hardware tie-up with Nvidia and a fresh endorsement from Barclays, propelling the stock to an all-time high. The combination has investors re-evaluating a company long seen as a legacy tech survivor rather than a cutting-edge contender.

Nvidia’s Vera-Rubin Platform Positions IBM as More Than an Also-Ran

At the Computex conference in Taipei, Nvidia named IBM as a key partner for its upcoming Vera-Rubin architecture, the next-generation platform designed to power AI factories — data centres built for the most demanding artificial intelligence workloads. IBM’s role spans system integration, cloud services, and secure AI storage infrastructure. The company’s Power Systems servers will incorporate Vera-Rubin accelerators for on-premises enterprise AI, and IBM Cloud plans to offer instances with Nvidia’s confidential computing capabilities.

The security dimension is central: IBM will leverage Nvidia’s BlueField-4 STX architecture to enforce hardware-level protection on AI data access. Initial partner systems are slated for delivery this autumn, with the BlueField-4 STX platforms expected in the second half of 2026.

For IBM, this is far more than a logo on a slide. The company’s customer base consists largely of large, regulated enterprises that prize data security, controllability, and local infrastructure. Nvidia’s next AI platform is a natural fit for precisely that audience.

Should investors sell immediately? Or is it worth buying IBM?

Barclays Adds Fuel With a Software-Centric Thesis

The stock had already been building momentum when Barclays analyst Raimo Lenschow initiated coverage with an Overweight rating and a $350 price target. In a bull case, he sees potential for $449. Lenschow’s rationale is straightforward: nearly half of IBM’s revenue comes from software, and he expects mid-single-digit organic revenue growth accompanied by expanding margins. He also points to a “quantum option” — long-term value from IBM’s quantum computing business that is not yet reflected in the share price.

Lenschow’s call landed at a propitious moment. IBM’s fiscal first-quarter 2026 results had already validated the narrative: total revenue rose 9.5% to $15.9 billion, gross margin improved to 56.2%, and the software segment grew 11% to $7.05 billion, beating analyst estimates. Red Hat returned to double-digit growth, and its OpenShift platform exceeded $2 billion in annual recurring revenue for the first time. CEO Arvind Krishna reaffirmed guidance of more than 5% revenue growth in constant currency and an increase in free cash flow of roughly $1 billion year over year.

A decade-old video clip of then-President Donald Trump calling Krishna a “legend” at a White House event recirculated during the rally, racking up over 700,000 views. While such political buzz rarely moves markets on its own, it added to the tailwind in a week already charged with AI euphoria, a Nvidia partnership, and fresh analyst support.

Historic Gains but Overbought Signals

The stock surged more than 10% in pre-market trading at one point and closed mid-session up 9.1%, hitting a new all-time high in U.S. trading. On a weekly basis, IBM posted its largest gain since April 2001, rising 17.3%. The May rally alone amounted to roughly 30%, the strongest monthly performance in nearly 24 years. In euro terms, the stock closed Monday at €275.25, a new 52-week high, and has gained 27.61% in seven trading days.

Yet the velocity is starting to raise eyebrows. The 14-day relative strength index sits at 72.6, firmly in overbought territory. The stock’s 40.23% advance over the past month has stretched its distance from the 200-day moving average to 17.91%. While nothing suggests an imminent collapse, the bar for further positive surprises is now high.

Market Skepticism and Rotation

Not everyone is buying the hype. Among analysts covering IBM, only ten rate it a Buy, while eleven recommend Hold. The average price target of $291.69 remains below the current level. That gap suggests the recent run-up has already priced in much of the good news.

IBM at a turning point? This analysis reveals what investors need to know now.

There is also evidence of a rotation within the quantum computing space. While IBM rallied, pure-play quantum names IonQ and Rigetti each lost about 4% on Monday. Capital appears to be flowing from speculative plays into established companies with a “quantum option” — a shift that benefits IBM precisely because its quantum ambitions are backed by a multi-billion-dollar operating business.

IBM has committed $10 billion over five years to its quantum computing programme, a market valued at just $1.4 billion in 2024 but growing from a low base. In May, the U.S. Commerce Department earmarked $2 billion in potential funding for nine domestic quantum computing companies. Although IBM is not among the direct beneficiaries, the policy spotlight reinforces the perception that the company is a credible participant in a strategic technology.

What Comes Next

For the months ahead, all eyes are on two milestones: the first Vera-Rubin system deliveries this autumn and early signs of demand for IBM’s cloud and infrastructure offerings tied to Nvidia’s technology. A visible link between Nvidia’s hardware and IBM’s revenue would give the rally a tangible foundation. Without that confirmation, the stock remains vulnerable to profit-taking after such an extraordinary run.

Ad

IBM Stock: New Analysis - 2 June

Fresh IBM information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated IBM analysis...

en | US4592001014 | IBM’S | boerse | 69468147 |